Insulin resistance is measured through blood tests that assess how effectively your body uses insulin to control blood sugar. The most accessible method is a calculation called HOMA-IR, which uses your fasting insulin and fasting glucose levels to produce a single score. Values above roughly 2.0 to 2.5 generally signal insulin resistance, though the exact threshold varies by population. Beyond HOMA-IR, several other tests and indirect markers can flag the problem at different stages.
The Gold Standard: The Clamp Test
The most precise way to measure insulin resistance is the hyperinsulinemic-euglycemic clamp, a procedure used almost exclusively in research settings. During the test, insulin is infused into your bloodstream at a high, steady rate while glucose is simultaneously dripped in to keep your blood sugar level stable. At high enough insulin doses, your liver stops producing its own glucose, so the only glucose entering your system is what the researchers are adding. The amount of glucose needed to maintain stable blood sugar directly reflects how sensitive your tissues are to insulin. If your body needs a lot of added glucose to stay level, your cells are responding well to insulin. If very little is needed, your cells are resisting it.
This test takes several hours, requires an IV line, and involves frequent blood draws, which is why it stays in the laboratory. It is, however, the benchmark against which every other insulin resistance measurement is validated.
HOMA-IR: The Most Common Clinical Test
For practical purposes, the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) is the most widely used measure. It requires a single fasting blood draw that checks both your glucose and insulin levels, then combines them in a simple formula: fasting insulin (in microunits per milliliter) multiplied by fasting glucose (in milligrams per deciliter), divided by 405.
Interpreting your score depends on the reference range your lab uses, but research in healthy, normal-weight adults places the upper limit of normal around 2.5. Scores at the 75th percentile (around 1.2 to 1.7 depending on sex) are sometimes used as an earlier threshold for concern, while the 90th percentile, roughly 2.0 to 2.25, is frequently cited as the point where insulin resistance becomes clinically meaningful. A score above 2.5 is widely considered abnormal.
One important limitation: the immunoassays labs use to measure insulin vary significantly from one manufacturer to another, and no universal standard reference range exists. That means a HOMA-IR score from one lab may not be directly comparable to a score from another. Tracking your number over time at the same lab gives you the most reliable picture of whether things are improving or worsening.
Fasting Insulin on Its Own
Some clinicians look at fasting insulin as a standalone marker. Standard lab reference ranges list normal fasting insulin below about 25 mIU/L, though typical values in healthy people run considerably lower. The challenge here is the same variability problem that affects HOMA-IR: different lab assays can produce different numbers for the same blood sample. Still, a fasting insulin level that sits at the high end of the reference range, even with normal blood sugar, can be an early signal. Your pancreas may be working overtime to keep glucose in check, a pattern that often precedes rising blood sugar by years.
The Triglyceride-to-HDL Ratio
If you already have a standard lipid panel, you can calculate a rough proxy for insulin resistance without any additional blood work. Divide your triglycerides by your HDL cholesterol (both in mg/dL). Research suggests that a ratio above approximately 2.5 for women and 2.8 for men warrants further investigation. Ethnicity matters here: a threshold of 3.0 performs well for Caucasian and Mexican American populations, while a cutoff of 2.0 is more appropriate for African Americans.
This ratio is not a replacement for direct insulin measurement, but it is free to calculate from labs you may already have, and it correlates meaningfully with more formal testing. A rising ratio over successive blood panels is worth flagging with your provider.
Metabolic Syndrome as an Indirect Signal
Metabolic syndrome is a cluster of five findings that, taken together, strongly suggest underlying insulin resistance. You meet the criteria if three or more of the following are present:
- Elevated waist circumference (typically above 40 inches for men, 35 inches for women)
- Elevated triglycerides (150 mg/dL or higher)
- Reduced HDL cholesterol (below 40 mg/dL for men, below 50 mg/dL for women)
- Elevated blood pressure (130/85 mmHg or higher)
- Elevated fasting glucose (100 mg/dL or higher)
None of these markers measure insulin directly, but the pattern they form is driven by insulin resistance in most cases. If you already meet three of these five criteria, formal insulin testing becomes less about diagnosis and more about establishing a baseline for tracking improvement.
QUICKI: Another Calculation From the Same Blood Draw
The Quantitative Insulin Sensitivity Check Index (QUICKI) uses the same fasting glucose and fasting insulin values as HOMA-IR but applies a different mathematical transformation (the inverse of the sum of their logarithms). It produces a number that correlates well with clamp test results and has been validated in people with high blood pressure, obesity, and type 2 diabetes. Your doctor is less likely to order it by name since HOMA-IR dominates clinical practice, but some research settings prefer it for its slightly better performance in certain populations.
The LP-IR Score
A newer option is the Lipoprotein Insulin Resistance score, which uses a specialized form of cholesterol testing called nuclear magnetic resonance spectroscopy. Instead of just measuring how much cholesterol you have, this test analyzes the size and concentration of your lipoprotein particles, specifically your VLDL, LDL, and HDL subsets. These particle characteristics shift in predictable ways when insulin resistance develops, often before blood sugar itself becomes abnormal.
In a large study following women over 20 years, each standard-deviation increase in LP-IR score nearly doubled the risk of developing type 2 diabetes. Even after adjusting for BMI, blood pressure, family history, and lifestyle, the score remained a strong independent predictor. This test is not yet routine, but it is commercially available and can be useful for people who want a deeper look at metabolic health beyond standard labs.
How to Prepare for Testing
Any test involving fasting insulin or fasting glucose requires you to fast for 8 to 12 hours beforehand. Water is fine, but food, juice, and caloric beverages will affect results. If you take biotin supplements (vitamin B7), or any multivitamin that contains biotin, stop taking them at least 24 hours before your blood draw, as biotin can interfere with certain immunoassays. Intense exercise the day before testing can also temporarily improve insulin sensitivity and skew results lower than your true baseline, so keep your activity level normal in the 24 hours leading up to the test.
For the most useful results, ask your provider to order both fasting insulin and fasting glucose together, which gives you the raw data for HOMA-IR. A lipid panel drawn at the same time lets you calculate your triglyceride-to-HDL ratio as a cross-check. These three data points, all from a single fasting blood draw, provide a practical and affordable picture of where you stand.